Abstract

1. Abstract
Deep vein thrombosis, pulmonary thromboembolism, myocardial infarction, and systemic arterial thrombosis have been reported recently due to Coronavirus 2019 [COVID-19] disease-induced hypercoagulability [6]. Phlegmasia cerulea dolens [FSD] is a serious condition with a 25–40% mortality rate. It is a rare and severe complication of deep vein thrombosis [4]. In this case report, we aim to present the treatment course of an 84-year-old male patient diagnosed with COVID-19 infection and ST-segment elevation myocardial infarction with FSD.